selected scholarly activity
-
conferences
- Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference. Current Oncology. 9970-10017. 2022
- Hyperpolarized 129Xe Magnetic Resonance Imaging for the Assessment of Bronchiolitis Obliterans Syndrome (BOS) and Other Late-Onset Non-Infectious Pulmonary Complications (LONIPCs) Following Hematopoietic Stem Cell Transplantation. American Journal of Respiratory and Critical Care Medicine. 2022
- Fitness Assessment of Elderly Patients with AML and Outcomes. Blood. 3379-3379. 2021
- OR40 Autologous stem cell transplant: A method of desensitization in the highly sensitised patient awaiting renal transplant. Human Immunology. 45-45. 2019
- Late hospitalizations among survivors of childhood, adolescence and young adulthood hematopoietic stem-cell transplantation performed for malignant indications. Bone Marrow Transplantation. 68-68. 2019
- subsequent malignant neoplasms after pediatric, adolescent and young adulthood stem-cell transplantation: a population-based cohort. Bone Marrow Transplantation. 61-62. 2019
- Remission to Transplantation Time in Acute Myeloid Leukemia. Transplantation and Cellular Therapy. S121-S122. 2019
- P015 Bone marrow donor selection in the presence of both allogeneic and syngeneic donors. Human Immunology. 72-72. 2018
- P053 DP donor specific antibodies pre-renal transplant: Mean fluorescence intensity and epitope pattern alone is not predictive of crossmatch result or clinical outcome. Human Immunology. 98-98. 2018
- P079High throughput HLA-B27 immunophenotyping; conversion to a 96 well plate. Human Immunology. 120-120. 2018
- P114 Repeat mismatch in renal transplantation: Is the original source of repeat mismatch more predictive than cPRA for antibody response post transplant?. Human Immunology. 137-137. 2017
- P234 Typing challenges associated with mixed chimerism. Human Immunology. 227-227. 2017
- Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non-Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplant. Blood. 917-917. 2011
- The Inappropriate Use of the SimpliRed D-Dimer Assay in the Diagnosis of Venous Thromboembolism. Blood. 1799-1799. 2011
-
journal articles
- Revaccination following CAR-T therapy: a needs assessment.. Hematology. 30:2519865. 2025
- Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.. JACC: Advances. 4:101760. 2025
- Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma.. Current Oncology. 32:118. 2025
- Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.. Transplantation and Cellular Therapy. 31:77.e1-77.e20. 2025
- Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology Residents. Blood. 144. 2024
- Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?. Blood. 144:7418-7420. 2024
- The Transcription Factor IRF8 Regulates the Sensitivity of AML Cells to LSD1 Inhibition and All-Trans Retinoic Acid. Blood. 144:2764-2765. 2024
- Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development. Current Oncology. 31:1426-1444. 2024
- Ureaplasma-Induced Hyperammonemia Syndrome - an Acute Complication Post Allogeneic Stem Cell Transplant. Blood. 142:6988-6988. 2023
- Analysis of the Impact of Whole Blood and T-Cell Donor Chimerism after Allogeneic Stem Cell Transplant. Blood. 142:2211-2211. 2023
- LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses. Blood. 142:6793-6793. 2023
- LSD1 Inhibition Synergizes with Venetoclax in Acute Myeloid Leukemia By Targeting Cellular Metabolism. Blood. 142:4156-4156. 2023
- Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis. Bone Marrow Transplantation. 58:478-490. 2023
- A Retrospective Cohort Study of Donor Cell Leukemia. Blood. 140:12916-12917. 2022
- Recognition of Hematopoietic Stem Cell Transplantation and Cellular Therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused Competence in Canada. Transplantation and Cellular Therapy. 27:702-706. 2021
- Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non−Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplant. Blood. 118:2091-2091. 2011
- The Inappropriate Use of the SimpliRed D-Dimer Assay in the Diagnosis of Venous Thromboembolism,. Blood. 118:4207-4207. 2011
- New Anticoagulants for the Prevention of Thromboembolism. Current Pharmaceutical Design. 16:3472-3474. 2010
- A logical approach to surgical thromboprophylaxis. Current Opinion in Hematology. 16:397-401. 2009
- DEVELOPMENT OF A CONTINUOUS CELL LINE, PBLE, FROM AN AMERICAN EEL PERIPHERAL BLOOD LEUKOCYTE PREPARATION. In Vitro Cellular and Developmental Biology - Animal. 42:263-263. 2006
- Development of a continuous cell line, PBLE, from an American Eel peripheral blood leukocyte preparation. In Vitro Cellular and Developmental Biology - Animal. 2006